Australian Retrospective Analysis of EGFRm Advanced & Metastatic NSCLC Patients Treated With 1L or 2L Osimertinib.

Clinical trial NCT07213076 · COMPLETED

Trial details

NCT number: NCT07213076
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer

Start date: 2025-07-04
Primary completion: 2025-11-10
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.